The World of Health & Medicine News

Amazon ropes in Fay to offer dietitian services on telehealth platform

Amazon ropes in Fay to offer dietitian services on telehealth platform

Amazon has teamed up with Fay to provide personalized, insurance-covered dietitian services through the e-commerce giant’s digital health platform, the nutrition care startup said on Tuesday.

WHY IT’S IMPORTANT

The move makes Fay the first nutrition care provider on Amazon’s Health Benefits Connector, which helps enrolled customers match with digital health companies for health conditions such as diabetes and musculoskeletal issues, as well as mental health support.

Fay uses artificial intelligence to match users with registered dietitians based on their goals and health history.

The startup did not disclose financial terms of the partnership.

CONTEXT

Amazon has been expanding into the healthcare industry for years, starting with the acquisition of PillPack for $750 million in 2018 and the launch of Amazon Pharmacy in 2020.

The company said it built its Health Benefits Connector, as nearly one in four U.S. adults remain unaware of the benefits available to them, even when provided by their employer or insurers.

Fay recently raised $50 million in a Series B round led by Goldman Sachs valuing it at $500 million, and operates a network of over 3,600 dietitians across all 50 U.S. states.

KEY QUOTES

“Nutrition is the single most underutilized lever in preventing chronic disease — and we believe it should be as easy to access as ordering from Amazon,” Sammy Faycurry, CEO of Fay, said.

spot_img

Explore more

spot_img

Bavarian Nordic signs EU smallpox and mpox vaccine contract for up...

Bavarian Nordic signs EU smallpox and mpox vaccine contract for up to 8 million doses Bavarian Nordic announced on Friday a new contract with the...

WHO says mpox now detected in more countries, with 17 deaths...

WHO says mpox now detected in more countries, with 17 deaths in Africa over six weeks The World Health Organization (WHO) said on Friday that...

Metsera the US obesity biotech at centre of Novo, Pfizer bidding...

Metsera the US obesity biotech at centre of Novo, Pfizer bidding war Metsera has become the obesity drug market's hottest ticket. The New York-based biotech is...

Eli Lilly says weight-loss pill a candidate for speedy approval under...

Eli Lilly says weight-loss pill a candidate for speedy approval under new US programme Eli Lilly said its experimental weight-loss pill met most criteria for...

BridgeBio surges as muscle disorder drug scores ‘best case’ trial win

BridgeBio surges as muscle disorder drug scores 'best case' trial win BridgeBio Pharma (BBIO.O), opens new tab said on Monday its experimental drug for a rare muscle...

US FDA warns four firms over unapproved fluoride drugs for children

US FDA warns four firms over unapproved fluoride drugs for children The U.S. Food and Drug Administration said on Friday it warned four companies that...

Inhibrx shares surge after bone cancer drug slows disease progression in...

Inhibrx shares surge after bone cancer drug slows disease progression in trial Inhibrx Biosciences said on Thursday its experimental drug helped slow the progression of...

Investors managing $11.5 trillion urge food companies to diversify away from...

Investors managing $11.5 trillion urge food companies to diversify away from animal proteins  Investors managing $11.5 trillion in assets are calling on major food companies...